Pharma Sources InsightJuly 11, 2025
Tag: Pharma Sources Insight , API , OOS , AI
Pharma Sources Insight is a unique source of updated coverages on current events and deep insights into hot areas of the pharma industry, from China to the world. It follows up new developments with those among the leading drug-manufacturers in China which further affect the world.
Now, join PharmaSources.com to get access to news of the Chinese pharmaceutical enterprises and medical suppliers to witness industrial changes through the exclusive perspectives of our expert writers into crucial aspects of the pharmaceutical field, all under PharmaSources.com and CPhI China.
FROM THE EDITOR
- FDA Guidance - Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production
BRAND STORY
- HUOHE PHARMACEUTICAL GROUP CO., LTD.
Global Pharma Industry
- Orphan Drugs as Strategic Assets: Lifecycle Patterns, Sales Resilience, and Market Impact
- Radioconjugate Therapy: The Approval Process and the Market Landscape
Drug R&D
- Small Molecule Drugs for Obesity: A Scalable, Oral Alternative to Peptide-Based Therapies
- Artificial Intelligence in Precision Cancer Care: Unlocking the Future of Personalized Oncology
Purchasing and Sales Strategies
- Global API Sourcing Trends: Why Quality Antibiotics Matter in 2025
Worth Reading:
Beyond Antibiotics: The Expanding Role of Anti-Infective APIs in Bacterial Infection
- Who Will Hold the Reins? An Analysis of Drug-Originating Countries for the US Market
PHARMA IN CHINA
- Made-in-China New Drugs: The Game and Breakthrough in the Over - 4 - Billion Market
- Popular Products and Companies at PharmaSources
INDUSTRY INSIGHT
- Green Transformation of the Pharmaceutical Industry: Can Continuous Manufacturing Outperform Traditional Production?
Worth Reading:
ESG Related Equipment in Pharmaceutical Industry
1. Register or Log in and click Download PSI for Free below.
2. Register or Log in to show the password, copy the password and unlock the full issue.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094
Follow Us: